Varian Medical Systems Announces Net Orders Growth Estimates for the First Quarter...

Varian Medical Systems Announces Net Orders Growth Estimates for the First
Quarter of Fiscal Year 2009
Company to announce full results for its fiscal first quarter on Jan. 29

PALO ALTO, Calif., Jan. 12 /PRNewswire-FirstCall/ -- Varian Medical
Systems (NYSE: VAR) today announced that it estimates the company will report
net orders growth in the first quarter of fiscal year 2009 in the range of 12
to 13 percent above the year-ago period with gains in all of its major
businesses.
Speaking to the financial community at the JP Morgan Healthcare Conference
in San Francisco, Tim Guertin, president and CEO of Varian Medical Systems,
said that compared to the year-ago quarter, net orders growth will approach 10
to 11 percent in the company's Oncology Systems business, with a 15 to 16
percent increase in the international market and a 6 to 7 percent gain in
North America. Compared to the year-ago period, net orders growth is
estimated to be about 21 percent in Varian's X-Ray Products business and about
15 percent in its Security and Inspection Products business.
"While there is unprecedented volatility and uncertainty in this economic
climate, the solid net orders growth in the first quarter gives us cautious
optimism about the prospects for our businesses in 2009," said Guertin.
Investor Conference Call
Varian Medical Systems is scheduled to announce its results for the first
quarter of fiscal year 2009 as well as its outlook for the full fiscal year
2009 on Thursday, January 29, 2009 when it will issue a press release at the
close of the market and hold a conference call at 2 p.m. The call can be
accessed via the company's web site at http://www.varian.com/investor where a
replay will be archived for a year. To access the call via telephone, dial
1-866-271-0675 from inside the U.S. or 1-617-213-8892 from outside the U.S.
and enter confirmation code 46529406. The replay can be accessed by dialing
1-888-286-8010 from inside the U.S. or 1-617-801-6888 from outside the U.S.
and entering confirmation code 54317886. The telephone replay will be
available through 5 p.m. PT, January 30, 2009.
Varian Medical Systems, Inc., of Palo Alto, California, is the world's
leading manufacturer of medical devices and software for treating cancer and
other medical conditions with radiotherapy, radiosurgery, proton therapy, and
brachytherapy. The company supplies informatics software for managing
comprehensive cancer clinics, radiotherapy centers and medical oncology
practices. Varian is a premier supplier of tubes and digital detectors for
X-ray imaging in medical, scientific, and industrial applications and also
supplies X-ray imaging products for cargo screening and industrial inspection.
Varian Medical Systems employs approximately 4,800 people who are located at
manufacturing sites in North America, Europe, and China and approximately 60
sales and support offices around the world. For more information, visit
http://www.varian.com.
Forward-Looking Statements
Except for historical information, this news release contains forward-
looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995. These statements include those expressing the company's
belief regarding fiscal year 2009 and are subject to risks and uncertainties
that could cause the company's actual results to differ materially from those
anticipated. Such risks and uncertainties include the effect of economic
conditions (particularly the highly volatile and uncertain economic
environment), currency exchange rates, and tax rates; credit availability for
capital expenditures for cancer care; demand for the company's products; the
company's ability to develop and commercialize new products; the company's
ability to meet demand for manufacturing capacity; the company's reliance on
sole or limited-source suppliers; the impact of reduced or limited demand by
sole purchasers of certain X-ray tubes; the company's ability to maintain or
increase operating margins; the impact of competitive products and pricing;
the effect of changes in accounting principles; the company's ability to meet
Food and Drug Administration and other regulatory requirements for product
clearances or to comply with Food and Drug Administration and other regulatory
regulations or procedures; the ability to make strategic acquisitions and to
successfully integrate the acquired operations into the company's business;
the possibility that litigation, including but not limited to litigation
matters involving material product liability claims, could harm future
revenues or require the company to pay uninsured claims; the effect of
environmental claims and expenses; the company's ability to protect the
company's intellectual property; the impact of managed care initiatives, other
health care reforms and/or third-party reimbursement levels; the potential
loss of key distributors or key personnel; consolidation in the X-ray tubes
market; the risk of operations interruptions due to terrorism, disease or
other events beyond the company's control; and the other risks listed from
time to time in the company's filings with the Securities and Exchange
Commission, which by this reference are incorporated herein. The company
assumes no obligation to update or revise the forward-looking statements in
this release because of new information, future events, or otherwise.
FOR INFORMATION CONTACT:
Elisha Finney (650) 424-6803
elisha.finney@varian.com

Spencer Sias (650) 424-5782
spencer.sias@varian.com

SOURCE Varian Medical Systems

Elisha Finney, +1-650-424-6803, elisha.finney@varian.com, or Spencer Sias,
+1-650-424-5782, spencer.sias@varian.com, both of Varian Medical Systems